These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20708408)

  • 1. 1,2,3-triazole analogs of combretastatin A-4 as potential microtubule-binding agents.
    Odlo K; Fournier-Dit-Chabert J; Ducki S; Gani OA; Sylte I; Hansen TV
    Bioorg Med Chem; 2010 Sep; 18(18):6874-85. PubMed ID: 20708408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1.
    Akselsen OW; Odlo K; Cheng JJ; Maccari G; Botta M; Hansen TV
    Bioorg Med Chem; 2012 Jan; 20(1):234-42. PubMed ID: 22137934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazolone-amide bridges and their effects on tubulin polymerization in cis-locked vinylogous combretastatin-A4 analogues: synthesis and biological evaluation.
    Li YW; Liu J; Liu N; Shi D; Zhou XT; Lv JG; Zhu J; Zheng CH; Zhou YJ
    Bioorg Med Chem; 2011 Jun; 19(11):3579-84. PubMed ID: 21536450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs.
    Fürst R; Zupkó I; Berényi A; Ecker GF; Rinner U
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6948-51. PubMed ID: 19879758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytotoxicity, docking study, and tubulin polymerization inhibitory activity of novel 1-(3,4-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxanilides.
    Aly OM; Beshr EA; Maklad RM; Mustafa M; Gamal-Eldeen AM
    Arch Pharm (Weinheim); 2014 Sep; 347(9):658-67. PubMed ID: 24996189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concise synthesis of pyrazole analogues of combretastatin A1 as potent anti-tubulin agents.
    Zaninetti R; Cortese SV; Aprile S; Massarotti A; Canonico PL; Sorba G; Grosa G; Genazzani AA; Pirali T
    ChemMedChem; 2013 Apr; 8(4):633-43. PubMed ID: 23436706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors.
    Ouyang X; Chen X; Piatnitski EL; Kiselyov AS; He HY; Mao Y; Pattaropong V; Yu Y; Kim KH; Kincaid J; Smith L; Wong WC; Lee SP; Milligan DL; Malikzay A; Fleming J; Gerlak J; Deevi D; Doody JF; Chiang HH; Patel SN; Wang Y; Rolser RL; Kussie P; Labelle M; Tuma MC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5154-9. PubMed ID: 16198562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
    J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
    Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
    J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of polymethoxylated 4-heteroarylcoumarins as tubulin assembly inhibitor.
    Ganina OG; Daras E; Bourgarel-Rey V; Peyrot V; Andresyuk AN; Finet JP; Fedorov AY; Beletskaya IP; Combes S
    Bioorg Med Chem; 2008 Oct; 16(19):8806-12. PubMed ID: 18805012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study.
    Mustafa M; Anwar S; Elgamal F; Ahmed ER; Aly OM
    Eur J Med Chem; 2019 Dec; 183():111697. PubMed ID: 31536891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2-anilinopyridine dimers as microtubule targeting and apoptosis inducing agents.
    Kamal A; Hussaini SM; Nayak VL; Malik MS; Sucharitha ML; Shaik TB; Ashraf M; Bagul C
    Bioorg Med Chem; 2014 Dec; 22(24):6755-67. PubMed ID: 25468039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution-phase parallel synthesis and biological evaluation of combretatriazoles.
    Cafici L; Pirali T; Condorelli F; Del Grosso E; Massarotti A; Sorba G; Canonico PL; Tron GC; Genazzani AA
    J Comb Chem; 2008; 10(5):732-40. PubMed ID: 18681482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of anti-microtubule N-(2-Arylindol-7-yl)benzenesulfonamide derivatives and their antitumor mechanisms.
    Chiou CT; Chen GS; Chen ML; Li H; Shi L; Huang XH; Dai WM; Chern JW
    ChemMedChem; 2010 Sep; 5(9):1489-97. PubMed ID: 20672297
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4.
    Mur Blanch N; Chabot GG; Quentin L; Scherman D; Bourg S; Dauzonne D
    Eur J Med Chem; 2012 Aug; 54():22-32. PubMed ID: 22647220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity.
    Cao TM; Durrant D; Tripathi A; Liu J; Tsai S; Kellogg GE; Simoni D; Lee RM
    Am J Hematol; 2008 May; 83(5):390-7. PubMed ID: 18175355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-(6-aryl-3(Z)-hexen-1,5-diynyl)anilines as a new class of potent antitubulin agents.
    Lo YH; Lin CC; Lin CF; Lin YT; Duh TH; Hong YR; Yang SH; Lin SR; Yang SC; Chang LS; Wu MJ
    J Med Chem; 2008 May; 51(9):2682-8. PubMed ID: 18386884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.